gens within six weeks were excluded. The selected cats underwent a clinical examination, and factors such as their sex, age, presence or history of URTD, vaccination status and clinical signs attributable to URTD, for example, coughing, sneezing, rhinitis/nasal discharge, an ocular discharge, conjunctivitis and respiratory effort, were recorded.
Polymerase chain reaction
Oropharyngeal and ocular samples were taken from each cat with plain cotton swabs (Medical Wire and Equipment), which were returned immediately after sampling to their covers. The swabs were kept on ice after sampling and then stored at -20°C until they were analysed. A quantitative PCR was performed for the identification of FHV, FCV, C felis and B bronchiseptica. Nucleic acid was isolated using the DNeasy 96 Tissue kit (Qiagen). Swabs were placed in 200 µl phosphatebuffered saline, 200 µl buffer AL and 20 µl proteinase K and incubated at 70°C for 20 minutes; subsequent procedures were as described by the manufacturer. Primers and Taqman probes were designed using Primer 3 to detect the thymidine kinase gene of FHV, Orf1 of FCV, the major outer membrane protein of C felis, and the FimA gene of B bronchiseptica, with the feline 28S rDNA gene as a positive control.
To reverse-transcribe the FCV RNA present in the nucleic acid samples to cDNA, the following reaction was set up on ice: 9·25 µl 2 x Platinum QRT-PCR Thermoscript (Invitrogen), 0·37 µl 10µM FCV reverse primer, 0·38 µl Thermoscript/ Platinum Taq mix and 8·5 µl template nucleic acid. The reaction was incubated at 55°C for 20 minutes to allow reverse transcription and then at 85°C for five minutes to inactivate the Thermoscript. The four-way multiplex real-time PCR assay to detect FHV, FCV and C felis and feline 28S rDNA was set up as follows: 12·5 µl 2 x Hotstartaq (Qiagen), 1·5 µl 50mM magnesium chloride, 100nM FHV primers and probe, 200 nm FCV primers and probe, 100nM C felis primers and probe, 200nM feline 28S primers and 100nM feline 28S probe, 5 µl cDNA/gDNA sample prepared as described above, and water to bring the volume to 25 µl. The reactions were incubated at 95°C for 15 minutes and then for 50 cycles of 95°C for 10 seconds and 60°C for 60 seconds. Fluorescence was detected at 530, 575, 620 and 680 nm at each annealing step at 60°C. The singleplex real-time PCR to detect B bronchiseptica was set up as follows: 12·5 µl 2 x Hotstartaq (Qiagen), 1·5 µl 50mM magnesium chloride, 200nM B bronchiseptica primers and 50nM B bronchiseptica probe, 5 µl gDNA and water to bring the volume to 25 µl. The reactions were incubated at 95°C for 15 minutes and then for 45 cycles of 95°C for five seconds and 60°C for 10 seconds. Fluorescence was detected at 530 nm at each annealing step at 60°C. All the reactions were run in duplicate.
The following gene sequences were used: FHV thymidine kinase gene (accession number M26660), FCV strain CV Orf1 (accession number M86379), C felis major outer membrane protein gene (accession number AF269258), B bronchiseptica FimA (accession number AF111796) and feline 28S rDNA (accession number AF353617); Table 1 gives the sequences of the primers and probes. All the primers and probes were synthesised by Cruachem. Fluorescently quenched probes were labelled with either 6-FAM, Hex, Texas Red or CY5 at the 5′ end and the appropriate black hole quencher at the 3′ end.
A positive result was obtained when the fluorescence of a sample increased above the threshold fluorescence value, determined as 10 times the mean standard deviation of fluorescence over the baseline cycles. The threshold cycle number was the PCR cycle at which the sample fluorescence equalled the threshold fluorescence.
Serology
Only cats more than four months old were eligible for blood sampling; a blood sample was collected into an EDTA tube and the tubes were kept on ice while being transported. After centrifugation at room temperature, the plasma was transferred into a polypropylene tube (PPN-tube-96; Micronic) and stored at -20°C. An ELISA was applied to detect antibodies to B bronchiseptica. Titres were calculated relative to a reference serum with a defined titre that was included in each ELISA plate (Jacobs and others 1993) , and titres less than or equal to 2 2 were considered negative.
An immunochromatographic test (DUO Speed; Bio Veto Test Laboratories) was used to detect feline leukaemia virus (FeLV) antigen and antibody to feline immunodeficiency virus (FIV).
Statistical analysis
Cats with antibodies to a pathogen were compared with cats without antibodies to that pathogen, and the individual cat was the statistical unit. The results are presented, where appropriate, as mean (sd). A univariate analysis was used to select variables for a multivariate analysis, with the level of significance (α) set at 0·25 for the univariate analysis and at 0·05 for the multivariate analysis. The results of the multivariate analysis are expressed as odds ratios (OR) with a 95 per cent confidence interval (CI). An OR is calculated by dividing the odds in the exposed group by the odds in the non-exposed group; an OR of 1 indicates that there was no association between exposure and disease, an OR greater than 1 indicates that the exposed group has an increased risk compared with the unexposed group, and an OR less than 1 indicates that the exposed group has a decreased risk compared with the unexposed group. First, a simple logistic regression (univariate analysis) was applied to each pathogen for each variable (PROC LOGISTIC, Release 8.2; SAS Institute), and the variables that were associated with the presence of a pathogen in an individual cat (P<0·25) were used in the multivariate logistic regression. In the multivariate model, variables were excluded from the model by a backward elimination procedure according to the method of Hosmer and Lemeshow (1989) . The least significant variable (based on Wald's statistic) was deleted, the model was refitted and the results were then compared (both the parameter estimates and the difference in -2 log likelihood of the model) with those of the previous run to check for confounding. With a change in parameter estimates (β) of more than 25 per cent, or 0·1 if β is between -0·4 and 0·4, the deleted variable was considered to be a confounder and included in the model again. This resulted in a model containing variables related to the presence of a pathogen.
For the multivariate model, the number of cats available for the analysis was reduced greatly owing to the values for some variables being missing. In this model interaction effects were tested one by one. All the interactions that were significantly related (P<0·05) to the presence of (antibodies to) a pathogen were then re-entered into the multivariate model and interactions were excluded as described above (Hosmer and Lemeshow 1989) . Because multiple measurements in each cattery cannot be regarded as independent units of observation, the association of factors with the outcome variable was corrected for the fact that the cats were clustered within a multi-cat household (PROC GENMOD/REPEATED SUBJECT=CATTERY/TYPE=EXCH; SAS). The exchangeable correlation structure fitted best and was used to account for withinhousehold variation.
RESULTS

Characteristics of the population of cats
A total of 1748 cats from 218 multicat households was included in the study. Because the information recorded on some of the questionnaires was incomplete, the details of the households and cats have been expressed as a proportion of the cases with the appropriate information available (Tables  2, 3 ). Swabs for the detection of FHV, FCV, C felis and B bronchiseptica were available from 1724 of the cats, and blood samples were taken from 1463 of them.
Most of the cats had been vaccinated against FHV and FCV (67 per cent, 1163 of 1728), but some of them had also been vaccinated against C felis (25 per cent, 294 of 1163). Rabies, feline panleukopenia (FPL), feline infectious peritonitis (FIP) and/or FeLV vaccines had also been administered to some of the cats. Of the fully completed questionnaires, signs of URTD were found in 20 per cent (105 of 533) of the cats that had not been vaccinated against FHV and FCV, and in 15 per cent (175 of 1136) of the cats that had been vaccinated against FHV and FCV (P=0·0289; OR=0·74; 95 per cent CI 0·57 to 0·97). An attenuated vaccine against FHV and FCV had been used in 683 of 1103 cats (62 per cent) and an inactivated vaccine had been used in the other 420 (38 per cent). Both vaccines reduced the prevalence of URTD and there was no significant difference in the prevalence of URTD between cats vaccinated with the attenuated and the inactivated vaccines (P=0·2535).
FeLV antigen was present in the blood samples from 4·2 per cent of the cats with URTD and in 1·2 per cent of the cats without URTD (P=0·0014; OR=3·70, 95 per cent CI 1·66 to 8·24). FIV antibodies were present in the blood of 7·7 per cent of the cats with URTD and in 3·8 per cent of the cats without URTD (P=0·0068; OR=2·12, 95 per cent CI 1·23 to 3·66).
Of the 218 households involved in the study, there were 50 (23 per cent) in France, 37 (17 per cent) in Italy, 37 in Germany, 23 (10 per cent) in the UK, 21 (10 per cent) in the Netherlands, 21 in Switzerland, 13 (6 per cent) in Spain, nine in Austria and seven in Sweden. Three households, with 60, 100 and 109 cats, were excluded from the multivariate analysis because they skewed the results. The mean (sd) number of cats in the other 215 households was 12 (7·3) with a median of 10, and a range from five to 45 cats. The mean age of 1713 of the cats was 3·6 (3·4) years, with a median of 2·6 years, and a range from 10 days to 20 years.
Multivariate analysis of FHV
The results of the multivariate analysis of FHV are shown in Table 4 . In the catteries with URTD, the prevalence of FHV was twice as high (16 per cent) as in the catteries with no URTD (8 per cent) (P=0·0205; OR=1·95, 95 per cent CI 1·11 to 3·44). A less than excellent level of hygiene in a cattery increased the prevalence of FHV (P=0·0121; OR=2·09, 95 per cent CI 1·17 to 3·71). A higher proportion of the cats that were infected with FCV were positive for FHV (18 per cent) than of the cats that were not infected with FCV (8 per cent) (P=0·0401; OR=1·62, 95 per cent CI 1·02 to 2·58).
Multivariate analysis of FCV
The results of the multivariate analysis of FCV are shown in 
Multivariate analysis of C felis
The results of the multivariate analysis of C felis are shown in Table 6 . A higher proportion of the cats in the catteries with URTD were infected with C felis (10 per cent) than of the cats in the catteries with no URTD (3 per cent) (P=0·0502; OR=2·55, 95 per cent CI 1·00 to 6·53). C felis was detected in a higher proportion of the cats in catteries with less than excellent hygiene (P=0·0490; OR=3·09, 95 per cent CI 1·01 to 9·51). A smaller proportion of the cats in catteries with dogs were infected with C felis than of those in catteries with no dogs (P=0·0106; OR=0·27, 95 per cent CI 0·10 to 0·74).
Multivariate analysis of B bronchiseptica
The results of the multivariate analysis of B bronchiseptica are shown in 
DISCUSSION
The prevalence of FCV, FHV and B bronchiseptica, but not C felis, was significantly higher in the multi-cat households with active URTD than in the multi-cat households without URTD, suggesting that each of these three pathogens plays a role in the disease. The prevalences of FHV and FCV in the catteries with URTD (16 per cent and 47 per cent, respectively) and in those with no URTD (8 per cent and 29 per cent, respectively) were slightly higher than the prevalences reported previously (Wardley and others 1974 , Coutts and others 1994 , Binns and others 2000 . This difference may have been due to the sampling criteria employed, but it may also be explained by the higher sensitivity of the PCR used in the present study than the virus isolation techniques used previously. The fact that carrier cats shed FCV almost continuously, whereas FHV is shed only intermittently between periods of latency, explains the generally higher isolation rate of FCV compared with FHV (Gaskell and Povey 1973 , Wardley 1976 , Binns and others 2000 . B bronchiseptica was detected in only 5 per cent of the cats with URTD and in 1·3 per cent of those without URTD. These low figures probably underestimate the significance of this pathogen in URTD in cats, because its seroprevalence indicates that the infection is widespread. Moreover, the OR suggests that the cats in households with URTD were three times more likely to have B bronchiseptica than cats in households without URTD; the risk also increased as the number of cats in the household increased.
During the study a PCR was developed to detect B bronchiseptica infection. The PCR has advantages over bacterial or viral isolation and is less time-consuming, less expensive and, most importantly for a study of this type, imposes fewer restrictions in terms of transport and logistics. However, the PCR method was found to be up to 10 times less sensitive than bacterial culture, owing to technical constraints with the DNA extraction step, and it was unable to detect fewer than 100 pathogens per swab.
The results of this study provide further evidence that B bronchiseptica is widespread in multi-cat households (McArdle and others 1994, Bergman and others 1997) and is associated with clinical signs of URTD in cats others 1999, Pasmans and others 2001) . The long-term asymptomatic carriage of B bronchiseptica (Coutts and others 1996) and its association with stress (Pedersen 1988) have been reported previously. It is possible that in the field carrier cats may remain culture-negative except during periods of stress. These findings underline the difficulty faced by veterinarians when dealing with feline URTD in clinical practice in assessing whether B bronchiseptica may be one of the causal agents.
Less than excellent hygiene was associated with an increase in the prevalence of FHV, FCV and C felis and of antibodies to B bronchiseptica. FHV is rather unstable in the environment but FCV can survive for eight to 10 days (Dawson and Willoughby 1999) . B bronchiseptica can survive long enough outside the host to allow it to be transmitted within infected mucus (Speakman and others 1999) , especially in a heavily contaminated environment. Previous work has shown that contact with dogs with URTD can be a risk factor for URTD in cats (Binns and others 1998 , Dawson and others 2000 . However, in this study, the presence of a dog decreased the risk of detection of FCV and/or C felis, the first time that this relationship has been observed. It may be an indirect effect related to the type of cattery, because there were far fewer rescue shelters with dogs (31 per cent) than breeding catteries (57 per cent) or private households (59 per cent). In the univariate analysis the prevalence of cats with antibodies to B bronchiseptica was higher in multi-cat households in which dogs were present (data not shown), suggesting that the pathogen was being transmitted between dogs and cats, as reported previously by Dawson and others (2000) . This variable was no longer significant in the multivariate analysis, probably owing to the small number of dogs with URTD that were involved in the study. It is perhaps not surprising that cats in rescue shelters were at a higher risk of URTD than cats in breeding catteries or private households. Moreover, the larger the number of cats the greater the risk, particularly for B bronchiseptica.
Papers & Articles
The recognition of acute infectious URTD in cats is usually straightforward, but the identification of the underlying infectious agents involved can be difficult, particularly when two (FCV and FHV) and sometimes three (FCV, FHV and B bronchiseptica) causal agents are present. This is particularly the case when B bronchiseptica is involved, because no definitive diagnostic test for this agent is readily available. The high prevalence of antibodies to B bronchiseptica in the present study clearly indicates that infection with this organism is widespread in European cats. The PCR, in spite of its limitations, showed that this pathogen plays a significant role in active URTD, particularly in larger multi-cat households. Minimising the risk factors identified in this study and optimising vaccination programmes in multi-cat households can contribute to reducing URTD. The inclusion of the novel intranasal vaccine against B bronchiseptica (Williams and others 2002) into vaccination programmes may help to reduce the prevalence of URTD in some multi-cat households. 
